Coloplast CEO Kristian Villumsen steps down from his CEO position as of today. The Board of Directors has asked Lars Rasmussen to step in as interim CEO. As the company is entering into a new strategy ...

Kepler Cheuvreux initiated coverage of Danish medtech company Coloplast with a “buy” rating and a target price of DKK482.

The contract is awarded for products that bring improvement to the healthcare industry.Coloplast, a global medical device company and market ...

The new intermittent catheter Luja™ addresses important risk factors for urinary tract infections, a significant burden for people using intermittent catheters as well as healthcare systems as a whole ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Though foreign-exchange headwinds have nagged at Coloplast COLO B, underlying demand remains robust and revenue growth remains on track to meet our full-year projections. We’re holding steady on our ...

There’s something fishy about Coloplast’s latest megadeal—literally. The Danish medtech announced (PDF) plans on Friday to acquire Kerecis, which uses fish skin as the basis of its wound care products ...

COPENHAGEN, July 7 (Reuters) - Coloplast (COLOb.CO), opens new tab has agreed to buy Iceland-based Kerecis, a biologic wound care firm that uses fish skin to develop tissue-transplant products, for up ...

Coloplast (CLPBY) faces operational challenges, with four consecutive top-line misses and reduced growth expectations, but retains a strong core franchise. CLPBY's CEO search remains unresolved, and ...

Coloplast A/S (COLO-B.CO), a medical devices manufacturer, reported Tuesday a loss in its second quarter, compared to prior year's profit, mainly hurt by a hefty impairment ...